For researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety.
A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson , emailed a complaint to the US Food and Drug Administration (FDA). Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails.
I have a lovely partner and 3 very active youngsters. We live in the earthquake ravaged Eastern Suburbs of Christchurch, New Zealand.
I began commenting/posting on Uncensored back in early 2012 looking for discussion and answers on the cause and agendas relating to our quakes.
I have always maintained an interest in ancient mysteries, UFOs, hidden agendas, geoengineering and secret societies and keep a close eye on current world events.
Since 2013 I have been an active member of theCONTrail.com community, being granted admin status and publishing many blogs and discussion threads.
At this time I'm now helping out with admin and moderation duties here at Uncensored where my online "life" began.
Grab your popcorn! Is our moon really a “Death Star”? We may be about to find out… Readers with good memories will recall a number of articles we’ve presented on the topic of lunar anomalies. Heck, the moon is an anomaly in itself. At one sixth the size of Earth […]